Day End Prices will be available on InvestorsLounge.com !


Pakistan Pharmaceutical: Shines with outperformance; triggers ahead – By JS Research

  • By: JS Global Capital Limited

  • - Published: Monday, 23 December 2024
PHARMACEUTICALS - Copy.jpg
<p></p><ul><li><span style="font-family:Arial, Helvetica, sans-serif;font-size:medium;">Pharma sector has outperformed the KSE-100 by 118% CYTD, after underperforming the market for 3-consecutive years Despite the rally, the sector remains attractive due to growing profitability driven by higher margins from deregulated nonessential drugs, recurring earnings growth, new product launches, strategic acquisitions, and expansion into new markets.</span></li></ul><ul><li><span style="font-family:Arial, Helvetica, sans-serif;font-size:medium;">We highlight, our sample of listed Pharma sector has reported net sales of Rs295bn during the past 4-quarters, arriving at a growth of 17%YoY mainly on account of higher prices post one-off increase granted during last year, wherein deregulation of non-essential medicines also contributed to the s...

Similar Reports